We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£495.00
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 3 months
The 2023-2028 Outlook for Substance Abuse Treatments in Japan
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 84 days · 84 data points (no recent data)
Historical
Generating forecast…
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
Price distribution over 84 days • 1 price levels
Price Analysis
Most common price: £495 (84 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 84 days
Description
This study covers the latent demand outlook for substance abuse treatments across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for substance abuse treatments. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of substance abuse treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Alkermes, Allergan, BioCorRx, GlaxoSmithKline, Glenmark Pharmaceuticals, Indivior, Mallinckrodt, Mylan NV, Noramco (part of SK Capital Partners), Pfizer, Purdue Pharma, Reckitt Benckiser Group, Sanofi, and Teva Pharmaceutical Industries. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).
Product Specifications
- Format
- paperback
- ASIN
- B0BP9P1VSV
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 28 November 2022
- Listed Since
- 09 December 2022
Similar Products You Might Like
99% match
The 2023-2028 Outlook for Substance Abuse Treatments in the United States
£520.00
11 Oct 2026
99% match
The 2023-2028 Outlook for Substance Abuse Treatments in India
£515.00
10 Oct 2026
97% match
The 2023-2028 Outlook for Alcohol Addiction Treatments in Japan
£495.00
03 Sep 2026
97% match
Complementary and Integrative Approaches to Substance Use Disorders (Substance Abuse Assessment, Interventions and Treatment)
£203.99
27 Aug 2026
97% match
The 2023-2028 Outlook for At-Home Drug of Abuse Testing in India
£515.00
05 Sep 2026
97% match
The 2023-2028 Outlook for At-Home Drug of Abuse Testing for US Zip Codes
£490.00
20 Oct 2026
97% match
The 2023-2028 Outlook for At-Home Drug of Abuse Testing in the United States
£520.00
09 Sep 2026
96% match
Subjective Definitions of Substance Abuse Problems:: Does Age Matter?
VDM Verlag
£42.00
14 Oct 2026
96% match
Substance Use Disorders and Behavioral Addictions: A Comprehensive Guide
Springer
£549.99
26 Aug 2026
96% match
Substance Use and Addiction Research: Methodology, Mechanisms, and Therapeutics
Elsevier
£111.99
22 Sep 2026
96% match
Substance Abuse in America: A Documentary and Reference Guide
Bloomsbury
£95.00
17 Sep 2026
96% match
The 2025-2030 World Outlook for Psychiatric and Substance Abuse Hospitals
Price unavailable
96% match
The 2023 Report on At-Home Drug of Abuse Testing: World Market Segmentation by City
£795.00
04 Sep 2026
96% match
Technology-Assisted Interventions for Substance Use Disorders
Springer
£73.10
23 Sep 2026
96% match
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in Japan
£495.00
14 Aug 2026
96% match
Technology-Assisted Interventions for Substance Use Disorders
Springer
£88.21
24 Sep 2026
96% match
Current Perspectives on Substance Use Disorders in South Asia: Public Mental Health Aspects
Springer
£107.28
19 Sep 2026
96% match
Substance Abuse - New Compounds and New Problems
IntechOpen
£119.00
19 Sep 2026
96% match
HANDBOOK OF SUBSTANCE MISUSE AND ADDICTION: A Practical Guide To Diagnosis, Pharmacotherapy, And Recovery
Price unavailable
96% match
Substance Abuse: From Princeples to Practice
Routledge
£62.99
10 Oct 2026
96% match
Rethinking Substance Abuse: What the Science Shows, and What We Should Do about It
Taylor & Francis
£40.81
19 Sep 2026
96% match
The 2023-2028 Outlook for Medical Devices for Opioid Use Disorder and Drug Addiction Treatments in the United States
£520.00
06 Sep 2026
96% match
Equipping the interdisciplinary workforce to treat Substance Use Disorders and Behavioral Health: Reducing The Stigma
Springer
£95.74
17 Sep 2026
96% match
Fundamentals of Substance Abuse Practice
Cengage Learning
£62.98
10 Oct 2026